The 2024 presidential election has ushered in Donald Trump’s return to the White House. With it, questions arise about the future of health care policy and implications for the ambulatory surgery center (ASC) industry. “President Trump was president for four years, so it’s not like we’re walking into this completely blind,” J. Blake Peart, managing director at health care advisory firm Vertess, told ASC News. The Affordable Care Act (ACA) remains a critical issue, Peart said. During his … [Read more...]
Tenet CEO Anticipates More Favorable Regulatory Landscape for ASC Consolidation
With the potential for regulatory changes on the horizon, particularly regarding antitrust policies, Tenet Healthcare Corporation (NYSE: THC) CEO Saum Sutaria said that a more favorable environment for mergers and acquisitions in the coming years could support further healthcare consolidation. Such a change would support ambulatory surgery center (ASC) dealmaking, although Sutaria noted that ASC merger and acquisition activity is unlikely to trigger antitrust concerns under any circumstances … [Read more...]
Tenet CEO: ASC Arm Thriving Amid ‘Transformative Year’
For Tenet Healthcare (NYSE: THC), 2024 has been a “transformative year.” In part, that transformation comes from Tenet making progress on its deleveraging goals by divesting hospital assets, a strategy that will, in turn, free the company up to execute on M&A opportunities and more moving forward. And at the same time, Tenet’s ambulatory surgery center (ASC) business – United Surgical Partners International (USPI) – continues to thrive, propelled by higher-acuity procedures shifting into … [Read more...]